HINGHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, today announced the addition of two ...

HINGHAM, Mass. - Microbot Medical Inc. (NASDAQ:MBOT), a pre-commercial stage medical technology company with a market capitalization of $48 million, announced the results of its ACCESS-PVI pivotal ...

HINGHAM, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, presented for the first time the data from ...

Revolutions Medical has a beta of -0.43, suggesting that its stock price is 143% less volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.51, suggesting that its stock price ...

BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market ...

In a recent SEC filing, Microbot Medical (NASDAQ:MBOT) Inc., a micro-cap medical device company with a market value of $42.84 million, detailed changes in compensation for several key executives.

In this article, we are going to take a look at where Microbot Medical Inc (NASDAQ:MBOT) stands against the other healthcare stocks. The healthcare sector is staging a comeback so far in 2025 ...

Microbot Medical Inc. (NASDAQ:MBOT), a company specializing in surgical and medical instruments, has awarded its CEO, Harel Gadot, a special bonus of $150,000. The decision was made on January 17 ...

Microbot Medical shares are trading higher by 22% during Monday's session. The company is raising $7 million through stock sales and investment options. Discover the top trade setups and ...